# Gland Pharma Limited – FDA Inspection, Feb 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/a1ce57fb-6700-494f-9a9f-b6ef80f6b697
Source feed: FDA_Inspections

> FDA inspection 1002974 of Gland Pharma Limited, February 03, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002974
- Company Name: Gland Pharma Limited
- Inspection Date: 2017-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1244548 - 2024-07-25](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/acffcfce-62b6-4883-95ee-555ed8943c50)
- [FDA Inspection 1210381 - 2023-07-14](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/a827d7e0-fc10-4952-baf6-b295d8269dbc)
- [FDA Inspection 1179407 - 2022-08-25](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/d25b4f34-1b29-4a94-be87-9f1e6e0cceab)
- [FDA Inspection 1090548 - 2019-05-16](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/826a0fc9-eaf4-4d9e-9236-b51098beb6ed)
- FDA Inspection 921536 - 2015-03-17

## Related Officers

- [Ademola O. Daramola](https://www.keypedia.com/people/ademola-o-daramola/814113a4-38bc-4ce5-b6af-09c7e688c0ec)
- [Issuing Officer](https://www.keypedia.com/people/katherine-d-adams/8520bed2-00c9-4f75-bf91-d92b14b58d3d)

Company: https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c